Annual EPS
-$0.18
-$0.14-297.83%
31 December 2023
Summary:
BioNexus Gene Lab annual earnings per share is currently -$0.18, with the most recent change of -$0.14 (-297.83%) on 31 December 2023. During the last 3 years, it has fallen by -$0.33 (-227.08%). BGLC annual EPS is now -227.08% below its all-time high of $0.14, reached on 01 December 2020.BGLC EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.07
-$0.09-762.83%
30 September 2024
Summary:
BioNexus Gene Lab quarterly earnings per share is currently -$0.07, with the most recent change of -$0.09 (-762.83%) on 30 September 2024. Over the past year, it has increased by +$0.08 (+51.83%). BGLC quarterly EPS is now -159.97% below its all-time high of $0.12, reached on 01 March 2020.BGLC Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$0.07
+$0.08+52.82%
30 September 2024
Summary:
BioNexus Gene Lab TTM earnings per share is currently -$0.07, with the most recent change of +$0.08 (+52.82%) on 30 September 2024. Over the past year, it has increased by +$0.14 (+66.13%). BGLC TTM EPS is now -150.00% below its all-time high of $0.14, reached on 01 December 2020.BGLC TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -297.8% | +51.8% | +66.1% |
| 3 y3 years | -227.1% | -461.8% | -335.3% |
| 5 y5 years | -6003.2% | -2780.8% | -300.0% |
BGLC EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -227.1% | at low | -461.8% | +51.8% | -298.4% | +66.1% |
| 5 y | 5 years | -227.1% | at low | -160.0% | +51.8% | -150.0% | +66.1% |
| alltime | all time | -227.1% | at low | -160.0% | +51.8% | -150.0% | +66.1% |
BioNexus Gene Lab EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.07(-762.8%) | -$0.07(-52.8%) |
| June 2024 | - | $0.01(-162.8%) | -$0.15(-16.1%) |
| Mar 2024 | - | -$0.02(-287.5%) | -$0.18(+6.4%) |
| Dec 2023 | -$0.18(+297.8%) | $0.01(-106.2%) | -$0.17(-19.7%) |
| Sept 2023 | - | -$0.16(+768.7%) | -$0.21(+240.7%) |
| June 2023 | - | -$0.02(+155.7%) | -$0.06(+15.3%) |
| Mar 2023 | - | -$0.01(-78.3%) | -$0.05(+17.9%) |
| Dec 2022 | -$0.05(-195.8%) | -$0.03(+507.5%) | -$0.05(+279.3%) |
| Sept 2022 | - | -$0.01(-44.8%) | -$0.01(-187.1%) |
| June 2022 | - | -$0.01(-900.0%) | $0.01(-45.5%) |
| Mar 2022 | - | $0.00(-25.0%) | $0.03(-29.8%) |
| Dec 2021 | $0.05 | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $0.00(-92.3%) | $0.04(+18.6%) |
| Sept 2021 | - | $0.02(+935.0%) | $0.03(-18.0%) |
| June 2021 | - | $0.00(-83.3%) | $0.04(+19.9%) |
| Mar 2021 | - | $0.01(-392.7%) | $0.03(-78.4%) |
| Dec 2020 | $0.14(-600.0%) | -$0.00(-115.0%) | $0.14(+4.9%) |
| Sept 2020 | - | $0.03(-752.4%) | $0.14(+28.0%) |
| June 2020 | - | -$0.00(-103.4%) | $0.11(+3.9%) |
| Mar 2020 | - | $0.12(-1256.5%) | $0.10(-458.7%) |
| Dec 2019 | -$0.03(-1029.0%) | -$0.01(+315.4%) | -$0.03(+60.0%) |
| Sept 2019 | - | -$0.00(-68.3%) | -$0.02(+16.9%) |
| June 2019 | - | -$0.01(+13.9%) | -$0.02(+113.9%) |
| Mar 2019 | - | -$0.01 | -$0.01 |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is BioNexus Gene Lab annual earnings per share?
- What is the all time high annual EPS for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual EPS year-on-year change?
- What is BioNexus Gene Lab quarterly earnings per share?
- What is the all time high quarterly EPS for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly EPS year-on-year change?
- What is BioNexus Gene Lab TTM earnings per share?
- What is the all time high TTM EPS for BioNexus Gene Lab?
- What is BioNexus Gene Lab TTM EPS year-on-year change?
What is BioNexus Gene Lab annual earnings per share?
The current annual EPS of BGLC is -$0.18
What is the all time high annual EPS for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual earnings per share is $0.14
What is BioNexus Gene Lab annual EPS year-on-year change?
Over the past year, BGLC annual earnings per share has changed by -$0.14 (-297.83%)
What is BioNexus Gene Lab quarterly earnings per share?
The current quarterly EPS of BGLC is -$0.07
What is the all time high quarterly EPS for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly earnings per share is $0.12
What is BioNexus Gene Lab quarterly EPS year-on-year change?
Over the past year, BGLC quarterly earnings per share has changed by +$0.08 (+51.83%)
What is BioNexus Gene Lab TTM earnings per share?
The current TTM EPS of BGLC is -$0.07
What is the all time high TTM EPS for BioNexus Gene Lab?
BioNexus Gene Lab all-time high TTM earnings per share is $0.14
What is BioNexus Gene Lab TTM EPS year-on-year change?
Over the past year, BGLC TTM earnings per share has changed by +$0.14 (+66.13%)